1. Home
  2. ADVB vs DKI Comparison

ADVB vs DKI Comparison

Compare ADVB & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVB
  • DKI
  • Stock Information
  • Founded
  • ADVB 2014
  • DKI 2018
  • Country
  • ADVB United States
  • DKI Hong Kong
  • Employees
  • ADVB N/A
  • DKI N/A
  • Industry
  • ADVB Medical Specialities
  • DKI
  • Sector
  • ADVB Health Care
  • DKI
  • Exchange
  • ADVB Nasdaq
  • DKI Nasdaq
  • Market Cap
  • ADVB 10.4M
  • DKI 11.9M
  • IPO Year
  • ADVB 2025
  • DKI 2025
  • Fundamental
  • Price
  • ADVB $0.44
  • DKI $0.53
  • Analyst Decision
  • ADVB
  • DKI
  • Analyst Count
  • ADVB 0
  • DKI 0
  • Target Price
  • ADVB N/A
  • DKI N/A
  • AVG Volume (30 Days)
  • ADVB 2.4M
  • DKI 302.4K
  • Earning Date
  • ADVB 10-27-2025
  • DKI 11-18-2025
  • Dividend Yield
  • ADVB N/A
  • DKI N/A
  • EPS Growth
  • ADVB N/A
  • DKI N/A
  • EPS
  • ADVB N/A
  • DKI 26.19
  • Revenue
  • ADVB N/A
  • DKI $10,204,329.00
  • Revenue This Year
  • ADVB N/A
  • DKI N/A
  • Revenue Next Year
  • ADVB N/A
  • DKI N/A
  • P/E Ratio
  • ADVB N/A
  • DKI $0.02
  • Revenue Growth
  • ADVB N/A
  • DKI 100.46
  • 52 Week Low
  • ADVB $0.34
  • DKI $0.49
  • 52 Week High
  • ADVB $4.10
  • DKI $15.00
  • Technical
  • Relative Strength Index (RSI)
  • ADVB 47.20
  • DKI N/A
  • Support Level
  • ADVB $0.43
  • DKI N/A
  • Resistance Level
  • ADVB $0.66
  • DKI N/A
  • Average True Range (ATR)
  • ADVB 0.07
  • DKI 0.00
  • MACD
  • ADVB 0.00
  • DKI 0.00
  • Stochastic Oscillator
  • ADVB 19.51
  • DKI 0.00

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

Share on Social Networks: